A nationwide study by the Hackensack Meridian Center for Discovery and Innovation (CDI) and Quest Diagnostics confirms that multidrug-resistant Klebsiella pneumoniae has moved from hospitals into U.S. communities. Researchers identified 267 multidrug-resistant strains across 42 states, with nearly 70% of samples showing resistance to the three most common oral antibiotics used to treat urinary tract infections (UTIs).
How is Klebsiella pneumoniae spreading in the community?
The bacteria are utilizing a gene known as CTX-M-15 to spread antibiotic resistance across diverse strains. According to Barry Kreiswirth, Ph.D., a microbiologist at the CDI, this gene is carried on plasmids—stray strands of DNA that bacteria easily swap with one another. This mechanism has allowed the pathogen to acquire not only antibiotic resistance but also tolerance for environmental stressors and metal exposure, which may help it survive outside of human hosts. Data from the Centers for Disease Control and Prevention (CDC) previously tracked a 53.3% increase in these ESBL-producing bacteria between 2012 and 2017, suggesting a long-term trend of community-based transmission that the new CDI study now confirms on a national scale.
Klebsiella pneumoniae is the second-leading cause of urinary tract infections globally and is responsible for approximately 600,000 deaths annually worldwide, according to the World Health Organization.
Who is most at risk for these resistant infections?
Elderly women face the highest risk, according to the study’s findings. Of the 2,000 samples analyzed by Quest Diagnostics and the CDI, more than two-thirds originated from female patients, and roughly 75% were from individuals over the age of 60. Because these strains are resistant to standard oral antibiotics like fluoroquinolones, Bactrim, and nitrofurantoin, clinicians are increasingly forced to rely on injectable antibiotics for treatment, noted Kreiswirth. While the study provides a vital genetic blueprint for developing future vaccines, the current reality remains that many common community infections are becoming significantly harder to treat with standard medical protocols.
What does this shift mean for public health?
Public health experts are reclassifying Klebsiella pneumoniae from a primarily hospital-acquired threat to a broader community concern. Meghan W. Starolis, Ph.D., senior science director at Quest Diagnostics, stated that the bacteria are now causing common infections that defy standard recommended treatments. Unlike historical outbreaks that were confined to clinical settings, the current genetic data shows regional and multi-state dissemination. This shift necessitates a change in how primary care physicians approach persistent UTIs in older populations, moving away from the assumption that these infections will respond to first-line oral medications.
If you or a family member are dealing with a recurring UTI, ask your healthcare provider if a culture and sensitivity test has been performed to ensure the prescribed antibiotic is effective against the specific strain present.
Frequently Asked Questions
Is Klebsiella pneumoniae contagious?
Yes, it is a bacteria that can spread through person-to-person contact, often in healthcare settings, but as the new study shows, it is increasingly circulating within general community environments.
Why are these bacteria becoming harder to treat?
The bacteria have evolved to share resistance genes through plasmids. This allows them to quickly adapt to common antibiotics, rendering standard oral treatments ineffective for many patients.
What should I do if I suspect a UTI?
Consult a physician immediately. Because of the rise in multidrug-resistant strains, self-treating or using leftover antibiotics can contribute to the growth of resistant bacteria.
Are you concerned about the rise of antibiotic-resistant infections in your community? Share your thoughts in the comments below or subscribe to our newsletter for the latest updates on infectious disease research and public health trends.
